W orldwide, an estimated 493,243, cases of invasive cervical cancer (ICC) occur each year and 273,505 women die of the disease. There is a global disparity in the incidence of cervical cancer, with the burden of cases occurring in less developed countries (83%), where effective cervical cancer screening and treatment services have often been difficult to implement (Fig 1). In more developed cou...

Cervical cancer remains a major public health challenge in developing countries. Despite the reduction in the incidence and mortality of cervical cancer in developed countries during the last two decades; developing countries have not been shown such changes in these two indices (Brotto et al., 2008). Although the cervical cancer incidence rate is low in Iran, nonetheless most cervical cancers ...

Cervical cancer is the second most common cancer after breast cancer in the world in women worldwide. More than 270, 000 women die from cervical cancer every year, more than 85% of these deaths are in low and middle income countries, main cause of this problem is poor access to screening and treatment services (World Health Organization, 2013a). According to WHO’s projections, deaths from cervi...

Cervical cancer is one of the leading cancer related death among women worldwide (Satija, 2013). Cervical cancer is the third most common cancer in women worldwide accounting for 9% of all female cancer and 9% death in females due to cervical cancer. Worldwide it is seventh cancer with estimated 530,000 new cases in 2008 accounting for 4% of cancer worldwide. More than 85% of the global burden ...

OBJECTIVE In the UK, women are requested to attend a cervical cancer test every 3 years as part of the NHS Cervical Screening Programme. This analysis compares the determinants of a cervical cancer screening examination with the determinants of a GP visit in the same year and investigates if cervical cancer screening participation is more likely for women who visit their GP. METHODS A recursi...

Cervical cancer is the most common cancer among Thai women, with the agestandardized incidence rate (ASR) of 24.7 per 100,000. In Thailand, an estimated 7,000 new cases occur each year. Cervical cancer is the third, behind liver and lung cancer, leading cause of cancer mortality among Thai women. There are approximately 7 women die every day from cervical cancer. The peak incidence of cervical ...

PURPOSE OF REVIEW This review is to inform the reader about the current situation with regard to treatment of cervical cancer in Africa and the barriers and complexities faced in most African countries. It also reviews the natural history of cervical cancer, the new 2009 International Federation of Gynecology and Obstetrics staging, and current treatment guidelines for cervical cancer. RECENT...

INTRODUCTION Cervical cancer is the third most common cancer among women worldwide, with about 500,000 new patients diagnosed and over 250,000 deaths every year. Cervical cancer screening offers protective benefits and is associated with a reduction in the incidence of invasive cervical cancer and cervical cancer mortality. But there is very low participation rate in screening for cervical canc...

BACKGROUND Cervical cancer is an important public health problem worldwide, which comprises approximately 12% of all cancers in women. In Tanzania, the estimated incidence rate is 30 to 40 per 100,000 women, indicating a high disease burden. Cervical cancer screening is acknowledged as currently the most effective approach for cervical cancer control, and it is associated with reduced incidence...

long bone metastasis in cervical cancer is a rare presentation generally seen in the lumbar column or ribs. the reported rates of bone metastases are between 15%-29%. it is associated with poor prognosis. bone scan and magnetic resonance imaging are useful techniques for diagnosis. in this case report, a 32-year old female with a previous history of cervical carcinoma figo stage iiia presented ...